baber/WOPTO huggingface dataset:
Patent PT-1987260-E (PT)
Title: Sealing device and method for sealing
Inventor: AZZALIN GRAZIANO
IPC: F16B41/00
Filed: 2007-02-16
Abstract: A sealing device (10) comprising a first sealing element (12) having a housing with an internal chamber therein and a second sealing element (14) having a shaft (34). When the first and second sealing elements are connected, the shaft (34) of the second sealing element extends into the internal chamber of the first sealing element through an opening in its housing. According to an important aspect of the invention, the first sealing element comprises a pressure sensor (46) connected to the internal chamber for sensing a pressure in the internal chamber; and a transmitter (48) for receiving a signal indicative of the pressure in the internal chamber and for transmitting the signal to a monitoring station.
Patent PT-2278775-E (PT)
Title: Multicasting method and apparatus
Inventor: MONTEIRO ANTONIO M
IPC: G06Q30/02
Filed: 1997-05-08
Abstract: A scalable architecture is disclosed for delivery of real-time information over a communications network. Embedded into the architecture is a control mechanism (10) that provides for the management and administration (60) of users (40) who are to receive the real-time information. Preferably, there are multiple channels of information available simultaneously to be delivered to users, each channel consisting of an independent stream of information. A user (40) chooses to tune in or tune out a particular channel, but does not choose the time at which the channel distributes its information. Advantageously, interactive (two-way) information can be incorporated into the system, multiple streams of information can be integrated for delivery to a user (40), and certain portions of the information being delivered can be tailored to the individual user (40).
Patent PT-656360-E (PT)
Inventor: TERASHIMA SHIRO
IPC: A61P35/00
Filed: 1993-08-19
Abstract: Trifluoromethylpyrroloindole carboxylic ester derivatives represented by general formulae (1) and (2) having an antitumor activity, optically active isomers thereof, and pharmacologically acceptable salts thereof, wherein R represents lower alkyl; R<1> represents an alpha -amino acid residue, etc.; R<2> represents hydrogen, a hydroxyl-protecting group, etc.; and Y represents halogen, arylsulfonyloxy, etc. <CHEM>
Patent PT-701808-E (PT)
Inventor: GIORDANO RUSSELL A
IPC: C04B41/89
Filed: 1995-09-18
Abstract: The invention relates to a process for producing a ceramic network material from a ceramic suspension by casting said suspension in a tooth-shaped mold. The suspension includes dispersed alumina particles in a medium containing deionized water with a pH in a range of about 4 to 5 and a concentration of polyvinyl alcohol in a range of about 0.5 to 1% by weight. The process includes the steps of slip casting the suspension in a plaster tooth mold and drying the molded suspension to draw the water from the suspension. The dried suspension then is fired in a furnace at a temperature in a range of about 1000 to 1400  DEG C to form a ceramic network. After the dried suspension has been fired and excess water and polyvinyl alcohol has been removed from the suspension, lanthanum aluminosilicate glass is infused to a coronal portion of the ceramic network to form a glass layer with a thickness in a range of about 1 to 2 mm within the ceramic network. A monomer, such as a monomer solution, then is infused to at least the portion of the ceramic network within the glass layer. Alternatively, the ceramic network may be infused with a metal alloy to form a layer on the coronal portion or with one or more monomers. <IMAGE>
Patent PT-777471-E (PT)
Inventor: CROOKS STEPHEN L
IPC: C07C323/43
Filed: 1995-07-14
Abstract: A method of inhibiting leukotriene biosynthesis, involving administering a compound of formula (I) wherein M, R, R', R'', and n are as defined herein. Also, a pharmaceutical composition involving such a compound and the use of such compounds in the manufacture of a pharmaceutical composition for inhibiting leukotriene biosynthesis.
Patent PT-789254-E (PT)
Inventor: OOSTHUIZEN MARTHINUS JACOBUS R
IPC: G08B13/24
Filed: 1993-11-18
Abstract: An identification system comprises an interrogator and a plurality of transponders. The interrogator includes a transmitter which transmits an interrogation signal and an inhibiting signal to the transponders, and a receiver for receiving response signals from the transponders. The interrogator also includes processor means for identifying the transponders from data in the received response signals and means for disabling transponders. The transponders which are disabled remain disabled whilst they continue to receive the inhibiting signal. Each transponder comprises receiving means, a code generator, and transmitter means connected to the code generator. On receipt of the transmitted interrogation signal the transponder transmits a response signal containing data which identifies it.
Patent PT-805220-E (PT)
Inventor: BEGUINOT JEAN
IPC: C22C38/00
Filed: 1997-04-11
Abstract: Low alloy steel comprises (wt.%): 0.35-0.5 carbon; 0.2-2.5 manganese; 0.005-0.2 aluminium; and up to 0.5 silicon; 4 nickel; 4 chromium; 1 copper; and 0.015 boron; and also molybdenum, tungsten, vanadium, niobium and tantalum, in which Mo+W/2 = 0-2% and V+Nb/2+Ta/4 = 0-0.5%. The proportions are also governed by the following equations: Cr+3 (Mo+W/2)+10 (V+Nb/2+Ta/4) ≥ 1; R = 3.8 C+10 Si+3.3 Mn+2.4 Ni+1.4 (Cr+Mo+W/2) ≤ 11; and Tr = 3.8 C+1.1 Mn+0.7 Ni+0.6 Cr+1.6 (Mo+W/2)+kB ≥ 3, in which kB is 0.5 if B is 0.0005% or more, and otherwise kB is zero; and R ≤ Max(2.33 Tr-1 ; 0.9 Tr+4). Also claimed are a block of such steel with characteristic dimension 20-1500 mm, a martensitic or bainitic crystal structure and hardness 250-370 Brinell, the use of the steel to make by casting a mould for forming plastics and a wire made of the steel for welding or making welding electrodes.
Patent PT-971709-E (PT)
Inventor: PANETTA JILL ANN
IPC: A61P25/00
Filed: 1997-10-06
Abstract: This invention relates to novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents.
Patent PT-895573-E (PT)
Inventor: WINTER UDO
IPC: F42B12/34
Filed: 1997-04-24
Abstract: PCT No. PCT/AT97/00078 Sec. 371 Date Oct. 20, 1998 Sec. 102(e) Date Oct. 20, 1998 PCT Filed Apr. 24, 1997 PCT Pub. No. WO97/40334 PCT Pub. Date Oct. 30, 1997An expansion projectile (1) with a projectile body (2) forms a central arbor (3) at its end face and a collar (4) coaxially surrounding the arbor (3), where the collar (4) has an outer shape (6) tapering towards the free collar edge (5), and between collar (4) and arbor (3) there is provided a cavity (7) open towards the front. In order to achieve a monobloc projectile free from lead with a high efficiency and a wide range of applications in an economic way, the arbor (3) consists of shaft (31) and tip (32) the collar (4) touches the arbor (3) at least in the transition area (33) between shaft (31) and tip (32), and the arbor (3) protrudes at least up to the axial height of the collar edge (5).
Patent PT-925284-E (PT)
Inventor: WERNER WALTER
IPC: C07D237/32
Filed: 1997-07-09
Abstract: PCT No. PCT/FI96/03632 Sec. 371 Date Jan. 28, 2000 Sec. 102(e) Date Jan. 28, 2000 PCT Filed Jul. 9, 1997 PCT Pub. No. WO98/07706 PCT Pub. Date Feb. 26, 1998Polycyclic phthalazines, in particular 2-substituted maduraphthalazines (10,12,15,16-tetrahydroxy-8-methoxy-11-methyl-1,9,14-trioxo-1,2,6,7,9,14-hexahydronaphthaceno-1,2-g-phthalazines), of formula I and their use against gram-positive bacterial strains, particularly against multi-resistant staphylococci (MRSA) and against glycopeptide-resistant, for example vancomycin-resistant, enterococci. The polycyclic phthalazines are thus suitable for preparing anti-bacterially effective pharmaceutical compositions. In formula I, R1 is carboxyalkyl or carboxyaryl, and R2 and R3 represent H or acyl (for example CO-alkyl or COO-alkyl), with R1 being different from optionally substituted carboxyphenyl when R3 represents C1-8 alkanoyl. The invention also relates to salts, amides and esters of compounds of formula I.
Patent PT-939628-E (PT)
Inventor: GETMAN DANIEL P
IPC: A61K31/17
Filed: 1997-07-22
Abstract: This invention is directed to proteinase (protease) inhibitors, and more particularly to thiol sulfone inhibitors for matrix metalloproteinase 13(MMP-13), compositions of proteinase inhibitors, intermediates for the syntheses of proteinase inhibitors, processes for the preparation of proteinase inhibitors and processes for treating pathological conditions associated with pathological matrix metalloproteinase activity related to MMP-13.
Patent PT-943664-E (PT)
Inventor: ENGBERT THEODOR
IPC: C09D7/61
Filed: 1999-03-05
Abstract: Transparent paint binders containing 0.5-25 wt% (based on paint solids) primary nano-scale particles which can be incorporated as solid, produced by jet dispersion of nano-scale particles into the binder. An Independent claim is included for a process for the production of these binders in which the preparation is taken in at least one pass through at least one device comprising at least one nozzle or slot with a bore diameter or width of 0.05-1 mm and a length to diameter ratio or depth to slot-width ratio of 1-10, with a pressure difference of at least 0.5 (preferably 1) Mpa between the nozzle and its outlet.
Patent PT-1090187-E (PT)
Inventor: PUTTKAMMER FRANK
IPC: G07D7/00
Filed: 1999-06-15
Abstract: The invention relates to a marking substance for security documents of the kind difficult to discern by counterfeiters. The preferred marking substance is polyethylene dioxythiophene polystyrene sulfonate and, more particularly, PEDT/PSS of the CPP105 formulation.
Patent PT-1117999-E (PT)
Inventor: SCHMIDT GUNTER
IPC: G01N27/62
Filed: 1999-10-01
Abstract: Provided is a method for characterizing a polypeptide or a population of polypeptides, which method comprises: (a) contacting a sample comprising one or more polypeptides with a first cleavage agent to generate polypeptide fragments; (b) isolating one or more polypeptide fragments, each fragment comprising the N-terminus or the C-terminus of the polypeptide from which it was fragmented; (c) identifying the isolated fragments by mass spectrometry; (d) repeating steps (a)-(c) on the sample using a second cleavage agent that cleaves at a difference site from the first cleavage agent; and (e) characterizing the one or more polypeptides in the sample from the fragments identified in steps (c) and (d).
Patent SG-80288-G (SG)
Title: Box for storing a stack of pictures
IPC: A47G1/14
Filed: 1988-11-29
Abstract: A container for accommodating a stack of pictures is disclosed. The container has a display window, a first chamber for accommodating a single picture at the window, and a second chamber separated from the first chamber wherein the remaining pictures of the stack can be loosely housed.
Patent SG-106791-G (SG)
Title: Means for parking read/write heads in a disc drive using the back-emf of the spindle motor to operate a stepper motor
IPC: G11B20/10
Filed: 1991-12-17
Abstract: Electronic circuitry is provided to position the read/write heads (10) in a designated landing zone when the electrical power is removed from the drive (27). when power is removed from the drive, the stored energy of the rotating spindle motor (27) is used as a source of electrical power and timing pulses to the stepper motor (30) which drives the actuator of the disc drive. The power generated by the spindle motor as it spins down is referred to as "back EMF". A sequencer circuit (50) is provided to couple the power and clock pulses to selected windings of the stepper motor (30) in an order that will cause the stepper motor to rotate in the direction necessary to move the transducer heads (10) to a predetermined park position at the inner diameter of the disc whenever power is removed from the disc drive. Since the location of the heads at power down may not be known, the timing of the pulses in such that a sufficient number of steps will be taken to move the transducer heads to the parking zone within the time allotted even if power down occurred when the heads were at the outermost track. Step pulses will continue to be generated until the back EMF of the spindle motor is insufficient to generate such pulses. After the transducer heads are at the predetermined parking location, any additional steps will cause the actuator to contact a mechanical "inner crash stop" designed to prevent damage to the transducer heads from contact with the clamp which retains the discs.
Patent IE-780186-L (IE)
Title: Imidazopyridazines
IPC: A61K31/50
Filed: 1978-01-27
Abstract: The present invention relates to 5 -bO-pyridazines. 
The compounds according to the present invention correspond to the following formula: 
[FR2380281A1]
Patent IE-790240-L (IE)
Title: Cyclopropane carboxylic acid esters
IPC: A23K1/16
Filed: 1979-02-08
Abstract: A compound selected from (S)- alpha -cyano3-phenoxybenzyl (1R,trans)-2,2-dimethyl-3-(2',2'- dichloro-1',2'-dibromoethyl)- cyclopropane-1 -carboxylate; (S)- alpha -cyano-3-phenoxybenzyl (1R,cis)-2,2-dimethyl-3-(2',2'-dibromo- 1',2'-dichloroethyl)-cyclopropane-1- carboxylate; 3,4,5,6-tetrahydrophthalimidomethyl (1R,trans)-2,2-dimethyl-3-(1',2',2',2'- tetrabromoethyl)-cyclopropane-1- carboxylate; 3,4,5,6-tetrahydrophthalimidomethyl (1R,cis)-2,2-dimethyl-3-(1',2',2',2'- tetrabromoethyl)-cyclopropane-1- carboxylate; (S)- alpha -cyano-3-phenoxybenzyl (1R,cis)-2,2-dimethyl-3-(1',2',2',2'- tetrachloroethyl)-cyclo-propane-1- carboxylate; and (R)- alpha -cyano-3-phenoxybenzyl (1R,trans)-2,2-dimethyl-3-(2',2'- dichloro-1',2'-dibromoethyl)-cyclo- propane-1-carboxylate which compounds possess interesting insecticidal activity. (From GB2016447 A) [FR2419932A2]
Patent IE-44617-L (IE)
Title: Solid electrolyte
IPC: H01M10/39
Filed: 1977-02-18
Abstract: Novel compounds or compositions are provided capable of serving as solid electrolytes involving intercalated dichalcogenides having a combination of a tetravalent metal ion with a metal ion of lower oxidation state and a compensating amount of alkali metal ions to provide a substantially electrically neutral structure. The compositions have the formula: AxMxT1-xX2 where A is an alkali metal ion, M is a metal ion of lower valence state than T, T is a metal capable of forming a stable substantially electrically non-conductive intercalatable chalcogenide and X is a chalogen. Also included are batteries employing the subject compositions as the solid electrolyte. (From US4237201 A) [FR2341953A1]
Patent IE-39023-L (IE)
Title: Display devices
IPC: G02F1/1503
Filed: 1974-03-08
Abstract: A device for the control of light transmission or reflection comprises one or more working electrodes, preferably arranged to form a display and having radiation transmission or reflection properties, an active material comprising an N(p-cyanophenyl) substituted derivative of a compound, usually bicyclic, having two conjugated nitrogen-containing rings in contact with the working electrode surface, a counter electrode, also in contact with the active material and ferrous ammonium sulphate as an auxiliary redox system.
[US3930717A]
Patent IE-860714-L (IE)
Title: Semiconductor device
IPC: H01L29/78
Filed: 1986-03-19
Abstract: A semiconductor device formed in a semiconductor substrate and having a gate electrode formed on the semiconductor substrate, source and drain regions are formed in said the semiconductor substrate. The source and drain regions are made of a first impurity region doped with impurities of an opposite conductivity type to that of a semiconductor substrate formed at portions adjacent to the edge of the gate electrode, a second impurity region doped with impurities of an opposite conductivity type to that of a semiconductor substrate formed at portions under the first impurity region, and a third impurity region doped with impurities of opposite conductivity type to that of a semiconductor substrate formed at portions spaced apart from the edge of the gate electrode. The impurities of the second impurity region have a diffusion coefficient larger than that of the impurities of the first impurity region. The third impurity region has a higher concentration than that of the first and the second impurity regions and in addition the impurities of the third impurity region have a diffusion coefficient smaller than that of the second impurity region.
[US4928163A]
Patent IE-33125-L (IE)
Title: Heterocyclic carboxylic acids
IPC: C07D307/85
Filed: 1969-05-29
Abstract: 1,266,766. Benzofuran and benzothiophen derivatives. J. R. GEIGY A.G. 29 May, 1969 [30 May, 1968], No. 27282/69. Heading C2C. Novel compounds I in which R is a C 1-6 alkyl group; X is O or S; Y 1 and Y 2 are H or CH 3 ; and Z 1 and Z 2 are H, F, Cl, Br, CH 3 , C 2 H 5 , CH 3 O or C 2 H 5 O, and their salts with bases are prepared (a) by splitting off H-Am from a compound II in which Am is a secondary amino radical (b) by reacting the appropriate 5-unsubstituted compound with an acid halide where Cl is halo or an anhydride or (c) by dehalogenating a compound III where Cl is halo, followed if desired by salt formation. Intermediates isolated are the compounds II, prepared by reaction of the appropriate compounds which compounds are described in Specification 1,265,882 with formaldehyde or paraformaldehyde and H-Am; and 2,3-dihydro- 5 ( 2 - bromo - 2 - bromomethyl - butyryl) - 6 - methylbenzofuran-2-carboxylic acid, prepared from the 5-unsubstituted compound and 2-bromo-2- bromomethyl-butyryl chloride. Pharmaceutical compositions comprise a compound I in association with a suitable carrier, are administered orally and have diuretic and saluretic activity.
[GB1266766A]
Patent IE-840743-L (IE)
Title: Determination of activated partial thromboplastin time
IPC: G01N33/86
Filed: 1984-03-27
Abstract: The method entails the use of a chromogenic substrate.
Patent IE-44819-L (IE)
Title: Isoxazoline derivatives
IPC: A01N43/80
Filed: 1977-04-14
Abstract: The fungicide contains, besides a phytologically acceptable inert carrier, at least one new active substance of the formula <IMAGE> in which the substituents are defined in claim 1. The fungicide can be used for controlling fungal phytopathogens which attack the leaves.
[GB1581583A]
Patent IE-35437-L (IE)
Title: Vaccine from bacteroides nodosus.
IPC: A61K39/02
Filed: 1971-07-06
Abstract: 1351343 Vaccine preparation NEW ZEALAND INVENTIONS DEVELOPMENT AUTHORITY 6 July 1971 [6 July 1970] 31684/71 Heading A5B [Also in Division C6] A process for preparing a vaccine effective against Bacteroides nodosus Beveridge (Mraz) infection in sheep and other ruminant animals involves anaerobically cultivating the microorganisms in the presence of carbon dioxide in a nutrient culture medium containing separately added L-arginine or a salt thereof e.g. the monohydrochloride, recovering from the cultured medium antigens that induce protection against Bacteroides nodosus infection and incorporating the recovered protective antigens in a vaccine in a conventional manner. The vaccines may be prepared from the bacterial cells, the supernatant fluid or the two combination.
[GB1351343A]
Patent FI-830493-L (FI)
Inventor: DIEHL MANFRED
IPC: C11D3/12
Filed: 1983-02-14
Abstract: There are provided aqueous pumpable stable suspensions of a water insoluble silicate capable of binding calcium ions which contain based on the total weight of the aqueous suspension (A) as the silicate capable of binding calcium 0.5 to 80 weight percent of a finely divided, bound water containing, synthetically produced, water insoluble compound of the general formula (Cat2/nO)x.Me2O3.(SiO2)y (I), in which Cat is a cation exchangeable with calcium and which has the valence n, x is a number from 0.7 to 1.5, Me is boron or aluminum and y is a number between 0.8 and 6 and (B) as a dispersingly active component 0.5 to 6 weight percent of a mixture of at least two different alkylphenolethoxylates of the formula    <IMAGE>  (II) where R is an alkyl group of 1 to 15 carbon atoms. The component A especially can be a zeolite A while component B can consist of two alkylphenolethoxylates of formula (II) in which m is 2 to 7 and m is 8 to 15. The suspension can be employed for the production of powdery washing agents and detergents.
Patent FI-854171-L (FI)
Inventor: TRIGGLE DAVID
IPC: A61P9/12
Filed: 1985-10-24
Abstract: 1. Compounds of the general formula (I)  see diagramm : EP0179386,P26,F3  in which R represents phenyl, pyridyl or the benzoxadiazolyl radical, the phenyl radical containing 1 or 2 identical or different substituents from the group comprising nitro, trifluoromethyl, fluorine, chlorine and cyano, R**1 and R**3 are identical of different and each represent alkyl with 1 to 4 carbon atoms, or one of the substituents R**1 or R**3 represents hydroxymethyl, amino or cyano, R**2 represents hydrogen or alkyl with 1 or 2 carbon atoms, A either represents an alkylene group which has up to 12 carbon atoms and is substituted by methyl, ethyl or propyl, and which is optionally substituted or interrupted by a phenyl group and/or is optionally interrupted by an oxygen or sulphur atom or a grouping of the formula -NR**6 , or A represents a straight-chain or branched alkylene group which has up to 12 carbon atoms and is optionally interrupted by an oxygen or sulphur atom or a grouping of the formula -NR**6 when a) R**4 represents phenyl, benzyl, CO-R**6 , CO2 -R**6' , CO-NR**6 R**7 , SO2 R6 or -CH2 -CHOH-CH2 -OR**8 , or b) R represents pyridyl or benzoxadiazolyl, or c) R**5 represents indolyl, or d) the alkylene chain is interrupted by a sulphur atom or the group -NR**6 or e) X represents COR**9 , wherein R**6 und R**7 are identical or different and each represent hydrogen, alkyl with up to 4 C atoms, benzyl or phenyl and wherein R**8 has the meaning given for R**5 and can be identical or different from this radical wherein R**9 represents alkyl which has 1 to 7 C atoms and is optionally substituted by halogen, cyano, alkoxy or dialkylamino with in each case 1-4 C atoms, or denotes phenyl, naphthyl, phenylalkyl or anilino or an amino, monoalkylamino or dialkylamino group with in each case 1 to 4 C atoms, the alkyl groups optionally forming, with the nitrogen atom a 5-membered to 7-membered ring which can contain an oxygen atom as a further hetero-atom and wherein R**6' has the meaning of R**6 , but does not denote hydrogen, R**4 represents hydrogen, or represents straight-chain or branched alkyl with 1 to 3 carbon atoms, or represents phenyl or benzyl, or represents a radical of the formula CO-R**6 , CO2 -R**6' , CO-NR**6 R**7 , SO2 -R**6 or -CH2 -CHOH-CH2 -OR**8 , wherein R**6 , R**6' , R**7 , R**8 und R**9 have the abovementioned meaning, R**5 represents phenyl, naphthyl or indolyl, the phenyl radical optionally being substituted by 1 or 2 identical or different substituents from the group comprising fluorine, chlorine, nitro, cyano, alkyl with 1 or 2 C atoms, NR**6 , R**7 , NR**6 COR**7 , the group CH2 -CO-NH2 or acetyl and X represents the group COOR**10 , wherein R**10 represents a straight-chain, branched or cyclic alkyl radical which has up to 12 C atoms and is optionally interrupted in the chain by an oxygen atom and/or is optionally substituted by fluorine, chlorine, hydroxyl, pyridyl, phenyl or amino, or represents the group COR**9 , wherein R**9 has the abovementioned meaning, and pharmaceutically acceptable acid addition salts thereof.
Patent IE-851116-L (IE)
Title: Process for the production of anode active materials¹for use in cells¹cells
IPC: C22C1/04
Filed: 1985-05-03
Abstract: Active anode materials comprising amalgamated zinc powder for use in cells, in which the corrosion of zinc is effectively inhibited by a smallest possible amount of mercury, may be produced by a process comprising atomizing molten zinc added with mercury to obtain pre-amalgamated zinc powder and bringing the thus obtained powder, which is dispersed in a liquid, into contact with mercury or an amalgam to further amalgamate said pre-amalgamated zinc powder. 
[EP0162411A2]